If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Trading Update

18 Jan 2024 07:00

RNS Number : 0703A
Centaur Media PLC
18 January 2024
 

Centaur Media plc

Incorporated in England and Wales

Registration number: 04948078

LEI: 2138005WK87G7DQRQI62

ISIN: GB0034291418

 

18 January 2024

Centaur Media Plc

("Centaur" or the "Group")

Trading Update

Centaur, an international provider of business intelligence, learning and specialist consultancy, provides a trading update ahead of publishing its results for the full year ended 31 December 2023 ("FY23") on 13 March 2024.

Trading Update

The Board is pleased to report that the Group expects to deliver good year-on-year growth in both Adjusted EBITDA1 and Adjusted EBITDA1 margin in FY23, with revenue on a continuing2 basis slightly below that of FY22 due to a decline in non-strategic Marketing Solutions and Recruitment revenue.

The Group's Adjusted EBITDA1 performance for FY23 is expected to generate a margin above 25%, reflecting the ongoing focus on strategically valuable revenue streams3 and the operational leverage inherent within Centaur's business. Despite the uncertain macroeconomic backdrop and sector-wide challenges, this growth in Adjusted EBITDA1 margin exceeds Centaur's profitability target, set three years ago in line with its Margin Acceleration Plan 2023 ("MAP23").

The much-publicised macro-economic environment, trading conditions and inflationary pressures witnessed in FY23 resulted in revenue slowing in the second half of the year. Accordingly, the Board maintains a cautious outlook as we open 2024.

Centaur's net cash balance (including short-term deposits) stood at £9.5m as at 31 December 2023 (£16.0m as at 31 December 2022) after payment of £8.9m of ordinary and special dividends during FY23.

Swag Mukerji, Chief Executive Officer, commented:

"Centaur continues to perform well despite the macroeconomic uncertainty that characterised 2023 for our customers. During this time, we have taken financial and operational steps to improve the efficiency of our business and I am very pleased that we have exceeded the profit margin target set out over 3 years ago.

"I am particularly proud that, despite the extreme upheaval of the last few years, we have significantly grown our profits and built a business with a high proportion of strategically valuable revenue generated from blue-chip customers. This provides a strong platform for our future strategy, which we will outline following our preliminary results."

-Ends-

 

1 Adjusted EBITDA is adjusted operating profit before depreciation and amortisation. Adjusted results exclude adjusting items, such as amortisation of acquired intangible assets, as detailed in note 4 of the Interim Report for the period ended 30 June 2023.

2 In December 2023, Centaur closed the Really B2B and Design Week brands within Xeim. On this basis, these brands will be disclosed in the 2023 annual report as discontinued operations and the FY22 results re-presented accordingly. The re-presented FY22 Group revenue on a continuing basis is £38.4m.

3 Centaur's strategically valuable revenue streams comprise Premium Content, Training and Advisory, and Events.

 

Enquiries

Centaur Media Plc

020 7970 4000

Swag Mukerji, Chief Executive Officer

Simon Longfield, Chief Financial Officer

Teneo

Zoë Watt

07713 157561

Note to editors

Centaur is an international provider of business intelligence, learning and specialist consultancy that helps ambitious leaders see around corners and deliver change in the Marketing and Legal verticals. Our suite of brands, which includes Econsultancy, Marketing Week, MW Mini MBA, Festival of Marketing, Influencer Intelligence and The Lawyer, provide deep sector expertise across the Marketing and Legal industries based on our customers' needs.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUBSWRSUUAAAR
Date   Source Headline
18th Apr 202311:47 amRNSDirector/PDMR Shareholding
12th Apr 20232:41 pmRNSDirector/PDMR Shareholding
4th Apr 20231:48 pmRNSAnnual Financial Report
21st Mar 20239:51 amRNSHolding(s) in Company
20th Mar 20233:33 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
20th Feb 20239:30 amRNSDirector/PDMR Shareholding
31st Jan 20239:01 amRNSHolding(s) in Company
23rd Jan 20239:25 amRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update & Declaration of a Special Dividend
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20222:19 pmRNSDirector/PDMR Shareholding
22nd Nov 20221:52 pmRNSDirector/PDMR Shareholding
16th Nov 20223:57 pmRNSDirector/PDMR Shareholding
24th Oct 20229:37 amRNSDirector/PDMR Shareholding
23rd Sep 202211:24 amRNSDirector/PDMR Shareholding
22nd Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 20225:13 pmRNSDirector/PDMR Shareholding
25th Jul 20229:50 amRNSDirector/PDMR Shareholding
20th Jul 20227:00 amRNSInterim Results
5th Jul 202210:30 amRNSDirector/PDMR Shareholding
23rd May 202210:33 amRNSDirector/PDMR Shareholding
16th May 20227:00 amRNSNon-Executive Director Appointment
12th May 202211:08 amRNSDirector/PDMR Shareholding
11th May 20223:09 pmRNSResult of AGM
21st Apr 202211:27 amRNSDirector/PDMR Shareholding
1st Apr 202211:54 amRNSAnnual Financial Report
25th Mar 202211:32 amRNSDirector/PDMR Shareholding
22nd Mar 20223:24 pmRNSDirector/PDMR Shareholding
18th Mar 20229:35 amRNSDirector/PDMR Shareholding
18th Mar 20229:31 amRNSHolding(s) in Company
16th Mar 20227:00 amRNSPreliminary results
22nd Feb 20223:03 pmRNSDirector/PDMR Shareholding
20th Jan 202210:59 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSTrading Update
21st Dec 20214:31 pmRNSDirector/PDMR Shareholding
22nd Nov 202111:24 amRNSDirector/PDMR Shareholding
12th Nov 20219:54 amRNSHolding(s) in Company
12th Nov 20219:52 amRNSHolding(s) in Company
10th Nov 202110:11 amRNSNotification of major holdings
1st Nov 20214:18 pmRNSHolding(s) in Company
1st Nov 20211:46 pmRNSHolding(s) in Company
1st Nov 202110:37 amRNSHolding(s) in Company
1st Nov 202110:33 amRNSHolding(s) in Company
20th Oct 202111:54 amRNSDirector/PDMR Shareholding
13th Oct 20217:00 amRNSTrading Update
6th Oct 20219:30 amRNSHolding(s) in Company
21st Sep 202110:31 amRNSDirector/PDMR Shareholding
7th Sep 202112:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.